Cargando…
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®
BACKGROUND: Accurate determination of the predictive markers human epidermal growth factor receptor 2 (HER2/ERBB2), estrogen receptor (ER/ESR1), progesterone receptor (PgR/PGR), and marker of proliferation Ki67 (MKI67) is indispensable for therapeutic decision making in early breast cancer. In this...
Autores principales: | Varga, Zsuzsanna, Lebeau, Annette, Bu, Hong, Hartmann, Arndt, Penault-Llorca, Frederique, Guerini-Rocco, Elena, Schraml, Peter, Symmans, Fraser, Stoehr, Robert, Teng, Xiaodong, Turzynski, Andreas, von Wasielewski, Reinhard, Gürtler, Claudia, Laible, Mark, Schlombs, Kornelia, Joensuu, Heikki, Keller, Thomas, Sinn, Peter, Sahin, Ugur, Bartlett, John, Viale, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426065/ https://www.ncbi.nlm.nih.gov/pubmed/28490348 http://dx.doi.org/10.1186/s13058-017-0848-z |
Ejemplares similares
-
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
por: Breyer, Johannes, et al.
Publicado: (2017) -
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment
por: Erber, Ramona, et al.
Publicado: (2021) -
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens
por: Laible, Mark, et al.
Publicado: (2016) -
B3-Läsionen der Mamma: Histologische, klinische und epidemiologische Aspekte: Update
por: Varga, Zsuzsanna, et al.
Publicado: (2023) -
ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6
por: Filipits, M., et al.
Publicado: (2021)